Robert LeBoyer
Stock Analyst at Noble Capital Markets
(1.18)
# 3,645
Out of 5,182 analysts
18
Total ratings
31.25%
Success rate
-0.26%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robert LeBoyer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNXP Tonix Pharmaceuticals Holding | Reiterates: Outperform | $70 | $12.71 | +450.75% | 2 | Mar 20, 2025 | |
| NTRB Nutriband | Initiates: Outperform | $13 | $3.76 | +245.74% | 1 | Jan 22, 2025 | |
| GOVX GeoVax Labs | Maintains: Outperform | $150 → $250 | $1.10 | +22,627.27% | 2 | Aug 19, 2024 | |
| UNCY Unicycive Therapeutics | Initiates: Outperform | $60 | $7.17 | +736.82% | 1 | Feb 14, 2024 | |
| CVKD Cadrenal Therapeutics | Initiates: Outperform | $60 | $5.33 | +1,025.70% | 1 | Dec 18, 2023 | |
| ELDN Eledon Pharmaceuticals | Initiates: Outperform | $10 | $3.48 | +187.36% | 1 | Sep 27, 2023 | |
| MAIA MAIA Biotechnology | Initiates: Outperform | $14 | $1.25 | +1,020.00% | 1 | Feb 21, 2023 | |
| LCTX Lineage Cell Therapeutics | Initiates: Outperform | $8 | $1.56 | +412.82% | 2 | Aug 19, 2021 | |
| PSTV Plus Therapeutics | Initiates: Buy | $3,000 | $5.95 | +50,320.17% | 1 | Jan 25, 2021 | |
| BNTC Benitec Biopharma | Downgrades: Neutral | n/a | $12.17 | - | 1 | Oct 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $3.37 | +256.08% | 1 | Sep 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9,900,000 | $2.26 | +437,143,892.58% | 1 | Aug 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $31.97 | - | 1 | Apr 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $2.55 | +488.24% | 2 | Mar 8, 2018 |
Tonix Pharmaceuticals Holding
Mar 20, 2025
Reiterates: Outperform
Price Target: $70
Current: $12.71
Upside: +450.75%
Nutriband
Jan 22, 2025
Initiates: Outperform
Price Target: $13
Current: $3.76
Upside: +245.74%
GeoVax Labs
Aug 19, 2024
Maintains: Outperform
Price Target: $150 → $250
Current: $1.10
Upside: +22,627.27%
Unicycive Therapeutics
Feb 14, 2024
Initiates: Outperform
Price Target: $60
Current: $7.17
Upside: +736.82%
Cadrenal Therapeutics
Dec 18, 2023
Initiates: Outperform
Price Target: $60
Current: $5.33
Upside: +1,025.70%
Eledon Pharmaceuticals
Sep 27, 2023
Initiates: Outperform
Price Target: $10
Current: $3.48
Upside: +187.36%
MAIA Biotechnology
Feb 21, 2023
Initiates: Outperform
Price Target: $14
Current: $1.25
Upside: +1,020.00%
Lineage Cell Therapeutics
Aug 19, 2021
Initiates: Outperform
Price Target: $8
Current: $1.56
Upside: +412.82%
Plus Therapeutics
Jan 25, 2021
Initiates: Buy
Price Target: $3,000
Current: $5.95
Upside: +50,320.17%
Benitec Biopharma
Oct 5, 2020
Downgrades: Neutral
Price Target: n/a
Current: $12.17
Upside: -
Sep 28, 2020
Initiates: Buy
Price Target: $12
Current: $3.37
Upside: +256.08%
Aug 24, 2020
Initiates: Buy
Price Target: $9,900,000
Current: $2.26
Upside: +437,143,892.58%
Apr 10, 2018
Downgrades: Neutral
Price Target: n/a
Current: $31.97
Upside: -
Mar 8, 2018
Initiates: Buy
Price Target: $15
Current: $2.55
Upside: +488.24%